Tessa Romero's Stock Ratings

JP Morgan Analyst

Tessa Romero is an analyst at JP Morgan. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025

Overall Average Return

14.2%

Smart Score

62.6%

Overall Average Return Percentile

72nd

Number of Ratings

63
Buy NowGet Alert
03/21/2025DYNBuy Now
Dyne Therapeutics
$11.4848.08%
Tessa Romero62%
$18 → $17MaintainsNeutralGet Alert
03/05/2025BHVNBuy Now
Biohaven
$29.87127.65%
Tessa Romero62%
$72 → $68MaintainsOverweightGet Alert
11/05/2024UPBBuy Now
Upstream Bio
$7.63398.03%
Tessa Romero62%
→ $38Initiates → OverweightGet Alert
11/05/2024NMRABuy Now
Neumora Therapeutics
$1.151204.35%
Tessa Romero62%
$18 → $15DowngradeOverweight → NeutralGet Alert
10/24/2024DYNBuy Now
Dyne Therapeutics
$11.48204.88%
Tessa Romero62%
$43 → $35DowngradeOverweight → NeutralGet Alert
10/24/2024MCRBBuy Now
Seres Therapeutics
$0.71—
Tessa Romero62%
—DowngradeNeutral → UnderweightGet Alert
10/14/2024SRRKBuy Now
Scholar Rock Holding
$33.70-8.01%
Tessa Romero62%
$18 → $31MaintainsOverweightGet Alert
10/03/2024SRRKBuy Now
Scholar Rock Holding
$33.70-46.59%
Tessa Romero62%
$20 → $18MaintainsOverweightGet Alert
10/03/2024BHVNBuy Now
Biohaven
$29.87127.65%
Tessa Romero62%
$55 → $68MaintainsOverweightGet Alert
09/05/2024CYTKBuy Now
Cytokinetics
$45.0957.46%
Tessa Romero62%
$65 → $71MaintainsOverweightGet Alert
08/13/2024EYPTBuy Now
EyePoint Pharmaceuticals
$6.24364.74%
Tessa Romero62%
$32 → $29MaintainsOverweightGet Alert
08/12/2024EWTXBuy Now
Edgewise Therapeutics
$22.8035.96%
Tessa Romero62%
$30 → $31MaintainsOverweightGet Alert
07/09/2024EWTXBuy Now
Edgewise Therapeutics
$22.8031.58%
Tessa Romero62%
$27 → $30MaintainsOverweightGet Alert
07/09/2024DYNBuy Now
Dyne Therapeutics
$11.48274.56%
Tessa Romero62%
$39 → $43MaintainsOverweightGet Alert
06/24/2024CYTKBuy Now
Cytokinetics
$45.0944.16%
Tessa Romero62%
$77 → $65MaintainsOverweightGet Alert
06/13/2024AGIOBuy Now
Agios Pharmaceuticals
$30.5050.82%
Tessa Romero62%
→ $46ReinstatesNeutral → NeutralGet Alert
06/04/2024EYPTBuy Now
EyePoint Pharmaceuticals
$6.24412.82%
Tessa Romero62%
$35 → $32MaintainsOverweightGet Alert
03/25/2024ACADBuy Now
ACADIA Pharmaceuticals
$17.1146.11%
Tessa Romero62%
$29 → $25MaintainsOverweightGet Alert
03/18/2024NMRABuy Now
Neumora Therapeutics
$1.151813.04%
Tessa Romero62%
$20 → $22MaintainsOverweightGet Alert
03/07/2024CYTKBuy Now
Cytokinetics
$45.0970.77%
Tessa Romero62%
$78 → $77MaintainsOverweightGet Alert
03/01/2024ACADBuy Now
ACADIA Pharmaceuticals
$17.1169.49%
Tessa Romero62%
$32 → $29MaintainsOverweightGet Alert
02/23/2024AGIOBuy Now
Agios Pharmaceuticals
$30.50-1.64%
Tessa Romero62%
$31 → $30MaintainsNeutralGet Alert
02/23/2024BHVNBuy Now
Biohaven
$29.8787.48%
Tessa Romero62%
$32 → $56MaintainsOverweightGet Alert
01/23/2024AGIOBuy Now
Agios Pharmaceuticals
$30.501.64%
Tessa Romero62%
$30 → $31MaintainsNeutralGet Alert
01/22/2024EYPTBuy Now
EyePoint Pharmaceuticals
$6.24460.9%
Tessa Romero62%
→ $35Initiates → OverweightGet Alert
11/28/2023LXEOBuy Now
Lexeo Therapeutics
$4.40354.55%
Tessa Romero62%
→ $20Initiates → OverweightGet Alert
11/20/2023BHVNBuy Now
Biohaven
$29.877.13%
Tessa Romero62%
$26 → $32MaintainsOverweightGet Alert
11/08/2023AGIOBuy Now
Agios Pharmaceuticals
$30.50-1.64%
Tessa Romero62%
$32 → $30MaintainsNeutralGet Alert
11/08/2023NMRABuy Now
Neumora Therapeutics
$1.151639.13%
Tessa Romero62%
$21 → $20MaintainsOverweightGet Alert
10/10/2023NMRABuy Now
Neumora Therapeutics
$1.151726.09%
Tessa Romero62%
→ $21Initiates → OverweightGet Alert
10/10/2023ACADBuy Now
ACADIA Pharmaceuticals
$17.1187.03%
Tessa Romero62%
$29 → $32UpgradeNeutral → OverweightGet Alert
08/22/2023YMABBuy Now
Y-mAbs Therapeutics
$5.0937.52%
Tessa Romero62%
$8 → $7MaintainsUnderweightGet Alert
08/16/2023BHVNBuy Now
Biohaven
$29.87-19.65%
Tessa Romero62%
$27 → $24MaintainsOverweightGet Alert
08/09/2023DYNBuy Now
Dyne Therapeutics
$11.4891.64%
Tessa Romero62%
$20 → $22MaintainsOverweightGet Alert
08/07/2023ACADBuy Now
ACADIA Pharmaceuticals
$17.1169.49%
Tessa Romero62%
$28 → $29MaintainsNeutralGet Alert
08/07/2023AGIOBuy Now
Agios Pharmaceuticals
$30.504.92%
Tessa Romero62%
$33 → $32MaintainsNeutralGet Alert
06/30/2023EWTXBuy Now
Edgewise Therapeutics
$22.809.65%
Tessa Romero62%
$24 → $25MaintainsOverweightGet Alert
05/16/2023EWTXBuy Now
Edgewise Therapeutics
$22.805.26%
Tessa Romero62%
$25 → $24MaintainsOverweightGet Alert
04/25/2023XENEBuy Now
Xenon Pharmaceuticals
$34.9057.59%
Tessa Romero62%
$54 → $55MaintainsOverweightGet Alert
04/21/2023MCRBBuy Now
Seres Therapeutics
$0.71889.54%
Tessa Romero62%
→ $7Initiates → NeutralGet Alert
03/20/2023ACADBuy Now
ACADIA Pharmaceuticals
$17.1122.74%
Tessa Romero62%
$19 → $21MaintainsNeutralGet Alert
03/20/2023CYTKBuy Now
Cytokinetics
$45.0915.32%
Tessa Romero62%
$55 → $52MaintainsOverweightGet Alert
02/28/2023EWTXBuy Now
Edgewise Therapeutics
$22.809.65%
Tessa Romero62%
$27 → $25MaintainsOverweightGet Alert
01/04/2023BHVNBuy Now
Biohaven
$29.87-23%
Tessa Romero62%
→ $23Initiates → OverweightGet Alert
12/01/2022AGIOBuy Now
Agios Pharmaceuticals
$30.508.2%
Tessa Romero62%
$48 → $33MaintainsNeutralGet Alert
11/29/2022DYNBuy Now
Dyne Therapeutics
$11.4856.79%
Tessa Romero62%
$24 → $18MaintainsOverweightGet Alert
11/18/2022SRRKBuy Now
Scholar Rock Holding
$33.70-40.65%
Tessa Romero62%
$38 → $20MaintainsOverweightGet Alert
11/14/2022ACADBuy Now
ACADIA Pharmaceuticals
$17.11-0.64%
Tessa Romero62%
$19 → $17MaintainsNeutralGet Alert
10/31/2022YMABBuy Now
Y-mAbs Therapeutics
$5.0937.52%
Tessa Romero62%
$16 → $7DowngradeNeutral → UnderweightGet Alert
07/21/2022XENEBuy Now
Xenon Pharmaceuticals
$34.9057.59%
Tessa Romero62%
→ $55Initiates → OverweightGet Alert
06/28/2022GBTBuy Now
Global Blood Therapeutics
——
Tessa Romero62%
$39 → $36MaintainsNeutralGet Alert
05/24/2022SRRKBuy Now
Scholar Rock Holding
$33.709.79%
Tessa Romero62%
$46 → $37MaintainsOverweightGet Alert
02/14/2022EWTXBuy Now
Edgewise Therapeutics
$22.8040.35%
Tessa Romero62%
$33 → $32MaintainsOverweightGet Alert
01/06/2022EWTXBuy Now
Edgewise Therapeutics
$22.8044.74%
Tessa Romero62%
$30 → $33MaintainsOverweightGet Alert
01/03/2022YMABBuy Now
Y-mAbs Therapeutics
$5.09430.45%
Tessa Romero62%
$30 → $27MaintainsNeutralGet Alert
11/16/2021YMABBuy Now
Y-mAbs Therapeutics
$5.09489.39%
Tessa Romero62%
$57 → $30DowngradeOverweight → NeutralGet Alert
06/28/2021GBTBuy Now
Global Blood Therapeutics
——
Tessa Romero62%
→ $36DowngradeOverweight → NeutralGet Alert
04/20/2021EWTXBuy Now
Edgewise Therapeutics
$22.8049.12%
Tessa Romero62%
→ $34Initiates → OverweightGet Alert
03/22/2021YMABBuy Now
Y-mAbs Therapeutics
$5.09921.61%
Tessa Romero62%
→ $52Assumes → OverweightGet Alert
03/02/2021ORTXBuy Now
Orchard Therapeutics
——
Tessa Romero62%
$140 → $150Assumes → OverweightGet Alert
01/06/2021SRRKBuy Now
Scholar Rock Holding
$33.7075.07%
Tessa Romero62%
→ $59Initiates → OverweightGet Alert
12/17/2019GBTBuy Now
Global Blood Therapeutics
——
Tessa Romero62%
$58 → $79MaintainsEqual-WeightGet Alert
01/04/2017GBTBuy Now
Global Blood Therapeutics
——
Tessa Romero62%
→ $25Initiates → OverweightGet Alert